Spago Nanomedical : Annual Report2023 - MarketScreener
Nanomedicine for ANNUAL...
Stay updated with breaking news from Enhanced Permeability. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nanomedicine for ANNUAL...
Prof. Yucai Wang and Assoc. Prof. Wei Jiang, leading a research team at the University of Science and Technology of China (USTC) within the Chinese Academy of Sciences (CAS), has unveiled the previously unknown mechanism of how tumor vascular basement membranes obstruct nanoparticles (NPs).
At the University of Toronto, scientists have come up with a new theory to describe how nanoparticles enter and exit the tumors they are intended to treat.
LUND, SWEDEN / ACCESSWIRE / November 8, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Intensive preparations to bring Tumorad into clinicJULY -SEPTEMBER IN BRIEF· Net sales for the quarter amounted
Breast cancer affects more than one million women per year worldwide. Through this study, we develop a nanoparticle-based drug delivery system to target breast cancer cells. Aspirin has been found to inhibit thromboembolic diseases with its tumor-preventing activity. As a consequence, it relieves disease symptoms and severity. Here, mesoporous Silica Nanoparticles (MNP) have been used to deliver Aspirin to the tumor location. MNP-based Aspirin in folic acid (F)-conjugated Polydopamine (MNP-Asp-PD-PG-F) vehicles are prepared for targeted breast cancer therapy. The vehicle hinges on MNP altered ...